0001437749-24-013866.txt : 20240430 0001437749-24-013866.hdr.sgml : 20240430 20240430091343 ACCESSION NUMBER: 0001437749-24-013866 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240426 FILED AS OF DATE: 20240430 DATE AS OF CHANGE: 20240430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBERTSON SANFORD CENTRAL INDEX KEY: 0001250105 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41905 FILM NUMBER: 24894256 MAIL ADDRESS: STREET 1: ONE LETTERMAN DRIVE STREET 2: BUILDING C SUITE 410 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASSAVA SCIENCES INC CENTRAL INDEX KEY: 0001069530 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 911911336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6801 N CAPITAL OF TEXAS HIGHWAY STREET 2: BUILDING 1; SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78731 BUSINESS PHONE: 512-501-2444 MAIL ADDRESS: STREET 1: 6801 N CAPITAL OF TEXAS HIGHWAY STREET 2: BUILDING 1; SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78731 FORMER COMPANY: FORMER CONFORMED NAME: PAIN THERAPEUTICS INC DATE OF NAME CHANGE: 20000309 4 1 rdgdoc.xml FORM 4 X0508 4 2024-04-26 0001069530 CASSAVA SCIENCES INC SAVA 0001250105 ROBERTSON SANFORD 6801 N CAPITAL OF TEXAS HWY, BLDG 1 SUITE 300 AUSTIN TX 78731 1 0 Common Stock 2024-04-26 4 M 0 69000 22 A 955851 D Common Stock 180000 I By family Common Stock Warrant 33 2024-01-03 4 A 0 72000 0 A 2024-01-03 2024-05-07 Common Stock 108000 72000 I By family Common Stock Warrant 33 2024-01-03 4 A 0 354740 0 A 2024-01-03 2024-05-07 Common Stock 532110 354740 D Common Stock Warrant 33 2024-04-26 4 M 0 46000 0 D 2024-01-03 2024-05-07 Common Stock 69000 308740 D Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16. Form 4 represents exercise of common stock warrants received on January 3, 2024 for cash. Holder received one and one-half shares of common stock for each common stock warrant exercised. /s/ Eric J. Schoen by Power of Attorney 2024-04-30